Abstract:The incidence of cervical cancer has declined significantly in recent years through improved screening systems and human papillomavirus(HPV) vaccination, but it remains one of the leading causes of death among women. Advanced stage, metastasis and drug-resistance are the main causes of death in cervical cancer patients. Therefore, a thorough understanding of the molecular mechanisms in the development of cervical cancer may provide new directions for the treatment of cervical cancer. It has been reported that long non-coding RNAs(lncRNAs) are emerging as important regulators in many biological processes. LncRNAs are a group of RNA with more than 200 nucleotides in length but cannot encode proteins, which can perform a variety of functions at the transcriptional, translational and post-translational levels. Dysregulated lncRNA can serve as potential biomarker and therapeutic target in cancer. This article discusses the regulatory mechanism of lncRAN in cervical cancer and its role in regulating highly conserved signaling pathways, so as to provide new ideas for the diagnosis and treatment of cervical cancer.